SARS-CoV-2/Coronavirus Vaccine

About Macrotope

Macrotope is a private, pre-clinical stage biotech firm pioneering an antigen-centric immunology platform. Its core technology, the patented MAV™ platform, engineers the conformational dynamics of protein antigens to enhance immunogenicity and B-cell engagement, leading to more diverse antibody libraries and improved vaccine candidates. The company is applying this platform to develop next-generation vaccines for infectious diseases like SARS-CoV-2 and to partner on therapeutic antibody discovery projects, with a strong emphasis on design for manufacturability and global health equity.

Therapeutic Areas